Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms

NCT ID: NCT04637230

Last Updated: 2022-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-01

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single-channel electrocardiograms (lead I of 12-lead surface ECG; 30 seconds) will be collected from subjects/patients at 11 clinical centers in Germany to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms. Heart rhythms of interest are normal sinus rhythm (SR), atrial fibrillation (AF), atrial premature beats (APBs), ventricular premature beats (VPBs), and nonsustained ventricular tachycardia (VT). Per diagnosis, 20,000 ECGs are required, for a total of 100,000 ECGs to be obtained from approximately 10,000 subjects/patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In phase 1 of a research project titled 'Prevention of stroke and sudden cardiac death by Recording of 1-Channel Electrocardiograms' (PRICE), a total of 100,000 30-sec single-channel ECGs (lead I of 12-lead surface ECG) will be collected from approximately 10,000 subjects/patients at 11 participating clinical centers in Germany. Relevant baseline clinical patient characteristics will also be recorded. The ECGs, diagnosed by an experienced electrophysiologist (diagnostic gold standard), will be fed into an Artificial Intelligence (AI) for the automatic detection of normal sinus rhythm (SR), atrial fibrillation (AF), atrial premature beats (APBs), ventricular premature beats (VPBs), and nonsustained ventricular tachycardia (VT). It is expected that the overall diagnostic accuracy of the AI against an experienced electrophysiologist will be on the order of 95%.

In PRICE phase 2, ECG diagnosis by the AI will be compared with the diagnosis by 3 general cardiologists of the same ECGs. It is expected that the AI will surpass the general cardiologists in terms of diagnostic accuracy.

The final clinical phase of the PRICE project will comprise a randomized controlled community trial of risk patients to establish the superiority in stroke prevention of AI detection of AF on smart-watch ECGs vs. no AF detection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sinus Rhythm Atrial Fibrillation Atrial Premature Complexes Ventricular Premature Complexes Ventricular Tachycardia, Nonsustained

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sinus Rhythm

Subjects/patients in normal sinus rhythm

Electrocardiogram analysis by Artificial Intelligence

Intervention Type DIAGNOSTIC_TEST

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Atrial Fibrillation

Patients with atrial fibrillation

Electrocardiogram analysis by Artificial Intelligence

Intervention Type DIAGNOSTIC_TEST

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Atrial Premature Complexes

Patients with atrial premature complexes in between sinus beats

Electrocardiogram analysis by Artificial Intelligence

Intervention Type DIAGNOSTIC_TEST

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Ventricular Premature Complexes

Patients with ventricular premature complexes in between sinus beats

Electrocardiogram analysis by Artificial Intelligence

Intervention Type DIAGNOSTIC_TEST

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Ventricular Tachycardia, Nonsustained

Patients with episodes of nonsustained ventricular tachycardia in between sinus beats

Electrocardiogram analysis by Artificial Intelligence

Intervention Type DIAGNOSTIC_TEST

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrocardiogram analysis by Artificial Intelligence

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Heart rhythm of interest present on ECG

Exclusion Criteria

* Patient incapable of or not willing to sign informed consent form
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

A-Rhythmik GmbH

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karl-Heinz Kuck, MD

Role: PRINCIPAL_INVESTIGATOR

Universitäres Herzzentrum, Lübeck, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitäres Herzzentrum, Lübeck, Germany

Lübeck, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Karl-Heinz Kuck, MD

Role: CONTACT

+49451 500 75301

Michael Schlüter, PhD

Role: CONTACT

+49172 4089325

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Roza Saraei, PhD

Role: primary

+49451 500 44542

Michael Schlüter, PhD

Role: backup

+49172 408 9325

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-139

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Arrhythmia Prediction Trial
NCT02175836 UNKNOWN
AI-Guided Left Bundle Branch Area Pacing
NCT07206602 NOT_YET_RECRUITING NA